Clinical Trial

The Lily Device Trial

Study acronym: PREVAIL
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to test if the Lily Device works to reduce chemotherapy induced hair loss in patients. It will also learn about the safety of the Lily Device. The main questions it aims to answer is: * Do patient preserve their hair using the Lily Device after 4 cycles of chemotherapy, when hair preservation is a Grade ≤1 graded by an independent healthcare professional on the Common Terminology Criteria for Adverse Events (CTCAE)? * What is the subject incidence of Grade 1 or above Adverse Device Events (ADE's)?
Trial Details
NCT Number NCT06786078
Lead Sponsor Luminate Medical, Inc.
Conditions Chemotherapy Induced Alopecia
Enrollment 85 participants
Start Date 2024-12-20
Primary Completion 2025-07 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-01-22